Baidu
map

JAMA Neurol:颈内动脉颅内段粥样硬化增高卒中风险

2014-03-04 lighthouse dxy

动脉粥样硬化性脑梗死是缺血性卒中最常见的类型。其中,颈内动脉颅内段的粥样硬化被认为是40岁以上人群卒中的最重要危险因素,也是各种卒中防治手段的主要干预靶点。目前,关于白种人中颅内动脉粥样硬化对卒中影响的研究仍较有限。曾有报道发现,当以颈内动脉颅内段的钙化(ICAC)作为动脉粥样硬化的指标,有超过80%的白种人存在颅内动脉粥样硬化。近期,来自于荷兰鹿特丹伊拉姆斯医学中心的M. Arfan Ikram

动脉粥样硬化性脑梗死是缺血性卒中最常见的类型。其中,颈内动脉颅内段的粥样硬化被认为是40岁以上人群卒中的最重要危险因素,也是各种卒中防治手段的主要干预靶点。目前,关于白种人中颅内动脉粥样硬化对卒中影响的研究仍较有限。曾有报道发现,当以颈内动脉颅内段的钙化(ICAC)作为动脉粥样硬化的指标,有超过80%的白种人存在颅内动脉粥样硬化。近期,来自于荷兰鹿特丹伊拉姆斯医学中心的M. Arfan Ikram教授等报道了一项为期6年的大样本队列研究结果,揭示了颅内动脉粥样硬化对白种人卒中的影响。

该研究于2003年至2006年之间随机入组了一共2323名无卒中的研究对象,平均年龄69.5岁,并采用CT成像对ICAC体积进行测量。对所有研究对象随访至2012年1月1日,以了解随访期间卒中的发生情况。6年内的总随访数为14055人年,共监测到91例卒中,其中74例为缺血性卒中。相关分析显示,基线时ICAC体积较大的个体随访期内发生卒中的风险明显增高,该作用不受其它心血管危险因素、超声成像的颈动脉斑块情况以及其它血管内的钙化影响。结果发现,ICAC每增加一个标准差的卒中和缺血性卒中风险比(HR)分别为1.43和1.39。该研究结果显示,大约有75%的卒中病例的发生和颈动脉颅内段钙化有关,而和主动脉弓以及颈外动脉钙化有关的卒中分别仅占45%和25%。

该研究提示颈动脉颅内段的粥样硬化可能是造成白种人卒中的主要危险因素,其重要性甚至高于其它近端血管病变。目前,卒中的干预防措施包括各种药物治疗以及血管内治疗手段,而不论是药物治疗还是介入治疗,动脉粥样硬化病变都是重要的干预靶点,这一研究的结果进一步为今后实施积极的卒中一级预防措施提供了重要依据。


图1. CT成像显示的颈动脉颅内段钙化

方框中的白色为轴位CT成像中的颈内动脉;B.从岩骨(底部图片)向上的连续4幅境内动脉颅内段的CT图像,红色信号为钙化。

原始出处:
Bos D1, Portegies ML2, van der Lugt A3, Bos MJ4, Koudstaal PJ5, Hofman A4, Krestin GP3, Franco OH4, Vernooij MW1, Ikram MA6.Intracranial Carotid Artery Atherosclerosis and the Risk of Stroke in Whites: The Rotterdam Study.JAMA Neurol. 2014 Feb 17. doi: 10.1001/jamaneurol.2013.6223. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1944362, encodeId=776019443625a, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Dec 18 00:51:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999386, encodeId=0dde199938681, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 28 08:51:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281164, encodeId=7e9e1281164b3, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561556, encodeId=60ff156155608, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567565, encodeId=e96d156e565c5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615730, encodeId=c0be1615e30a4, content=<a href='/topic/show?id=4b501005114a' target=_blank style='color:#2F92EE;'>#颈内动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100511, encryptionId=4b501005114a, topicName=颈内动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71c019667486, createdName=644982816_68283327, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1944362, encodeId=776019443625a, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Dec 18 00:51:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999386, encodeId=0dde199938681, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 28 08:51:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281164, encodeId=7e9e1281164b3, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561556, encodeId=60ff156155608, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567565, encodeId=e96d156e565c5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615730, encodeId=c0be1615e30a4, content=<a href='/topic/show?id=4b501005114a' target=_blank style='color:#2F92EE;'>#颈内动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100511, encryptionId=4b501005114a, topicName=颈内动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71c019667486, createdName=644982816_68283327, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=)]
    2014-12-28 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1944362, encodeId=776019443625a, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Dec 18 00:51:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999386, encodeId=0dde199938681, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 28 08:51:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281164, encodeId=7e9e1281164b3, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561556, encodeId=60ff156155608, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567565, encodeId=e96d156e565c5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615730, encodeId=c0be1615e30a4, content=<a href='/topic/show?id=4b501005114a' target=_blank style='color:#2F92EE;'>#颈内动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100511, encryptionId=4b501005114a, topicName=颈内动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71c019667486, createdName=644982816_68283327, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1944362, encodeId=776019443625a, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Dec 18 00:51:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999386, encodeId=0dde199938681, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 28 08:51:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281164, encodeId=7e9e1281164b3, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561556, encodeId=60ff156155608, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567565, encodeId=e96d156e565c5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615730, encodeId=c0be1615e30a4, content=<a href='/topic/show?id=4b501005114a' target=_blank style='color:#2F92EE;'>#颈内动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100511, encryptionId=4b501005114a, topicName=颈内动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71c019667486, createdName=644982816_68283327, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=)]
    2014-03-06 liuxiaona
  5. [GetPortalCommentsPageByObjectIdResponse(id=1944362, encodeId=776019443625a, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Dec 18 00:51:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999386, encodeId=0dde199938681, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 28 08:51:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281164, encodeId=7e9e1281164b3, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561556, encodeId=60ff156155608, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567565, encodeId=e96d156e565c5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615730, encodeId=c0be1615e30a4, content=<a href='/topic/show?id=4b501005114a' target=_blank style='color:#2F92EE;'>#颈内动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100511, encryptionId=4b501005114a, topicName=颈内动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71c019667486, createdName=644982816_68283327, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=)]
    2014-03-06 liuxiaona
  6. [GetPortalCommentsPageByObjectIdResponse(id=1944362, encodeId=776019443625a, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Dec 18 00:51:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999386, encodeId=0dde199938681, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 28 08:51:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281164, encodeId=7e9e1281164b3, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561556, encodeId=60ff156155608, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567565, encodeId=e96d156e565c5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615730, encodeId=c0be1615e30a4, content=<a href='/topic/show?id=4b501005114a' target=_blank style='color:#2F92EE;'>#颈内动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100511, encryptionId=4b501005114a, topicName=颈内动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71c019667486, createdName=644982816_68283327, createdTime=Thu Mar 06 04:51:00 CST 2014, time=2014-03-06, status=1, ipAttribution=)]

相关资讯

BBA :南京大学动脉粥样硬化研究取得新进展

南京大学生命科学学院罗兰教授课题组在动脉粥样硬化的研究上取得了新进展。该课题组研究了GSTpi对于血管紧张素诱导的血管平滑肌细胞增殖、迁移和肥厚的干预。RNAi沉默实验揭露了GSTpi能够抑制血管平滑肌细胞的增殖、迁移、肥厚和细胞周期从G0/G1期到S期。免疫沉淀、AXIMA MALDI-TOF和激光共聚焦实验显示GSTpi能够直接与细胞信号转导重要蛋白之一STAT3结合,并减弱了血管紧张素诱导的

JCEM:低骨密度或与亚临床动脉粥样硬化无关

研究要点:该研究探讨骨矿密度与亚临床动脉粥样硬化之间的关系;发现仅在校正年龄后,女性受试者的总髋部骨密度与踝肱比呈正相关;在完全校正的性别特异性回归模型中,骨密度与踝肱比、脉搏波传导速度和颈动脉内膜中层厚度无关。亚洲人中骨矿密度(BMD)与动脉粥样硬化之间相关性的临床意义尚不清楚。为了探讨BMD与亚临床动脉粥样硬化之间的关系,来自沈阳中国医科大学第一附属医院老年科白小涓教授及其团队进行了一项研究,

IAS:non-HDL-C作为降脂治疗靶标更优

近期,国际动脉粥样硬化学会(IAS)公布全球血脂代谢异常处理指南。该指南以来源于多个领域的证据为依据,明确指出动脉粥样硬化性胆固醇既可指低密度脂蛋白胆固醇(LDL-C),也可指非高密度脂蛋白胆固醇(non-HDL-C),但更支持以后者作为降脂治疗靶标;强调动脉粥样硬化性心血管疾病(ASCVD)一级预防重在生活方式干预,而二级预防需依靠药物;血脂代谢异常患者的ASCVD风险评估应评估长期风险,而非短

脂肪酸比例相异的鱼肉对于动脉粥样硬化危险因子之不同效应

本研究目的,在于评估摄取n-6 及n-3 脂肪酸比例不同之黑鲷鱼片对于动脉粥样硬化生化指标的影响。共有20 位健康的受试者参与此随机单盲交叉试验。研究初始,随机将受试者分为A、B 两组,A 组先给予每周大约630克黑鲷鱼片(FM-以全鱼饲料喂养),连续摄食10周后,更换为以混合50%植物性蛋白饲料喂养的黑鲷鱼(PP),B组则相反。 A组在给予FM 黑鲷鱼的介入

朱建华:动脉粥样硬化炎症机制新视点

朱建华 浙江大学医学院附属第一医院心内科  主任   近25年来,国内外学者逐渐认识到粥样硬化发生的免疫机制。一系列基因敲除的动脉粥样硬化动物模型实验证实初始免疫与被动免疫启动并调节着AS的发生与发展,并可以成为干预AS的一种手段。  &nb

七成老年耳聋患者患有动脉粥样硬化

随着医疗技术的进步、经济的发展,人的平均寿命亦相应提高了许多,因而社会老年化趋势也愈加显著,对老年病的防治也日益受到社会和有关部门的关注。 老年性耳聋是老年病之一。我们在介绍听力的自然衰退时曾告诉大家,听觉器官是人体器官中衰退最早的器官,衰退从听觉器官发育、发展到顶峰时(即十几岁时)就开始了,到了40岁以后身体各器官均出现老化退变,以耳聋、眼花最为突出。老化的程度可因

Baidu
map
Baidu
map
Baidu
map